Patents by Inventor Michel Homerin

Michel Homerin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION COMBINING TENATOPRAZOLE AND A HISTAMINE H2-RECEPTOR ANTAGONIST
    Publication number: 20120122919
    Abstract: The invention relates to a novel pharmaceutical combination. The inventive pharmaceutical composition, which is intended for the treatment of pathologies linked to gastric hyperacidity, comprises a combination of tenatoprazole and one or more histamine H2-receptor antagonists preferably selected from cimetidine, ranitidine, famotidine and nizatidine. The invention is particularly suitable for the treatment of duodenal and gastric ulcers and the symptoms of, and lesions caused by, gastroesophageal reflux.
    Type: Application
    Filed: November 15, 2011
    Publication date: May 17, 2012
    Applicants: MITSUBISHI PHARMA CORPORATION, SIDEM PHARMA
    Inventors: François Schutze, Suzy Charbit, Hervé Ficheux, Michel Homerin, Alain Taccoen, Nathalie Taccoen, Yoshio Inaba
  • USE OF TENATOPRAZOLE FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
    Publication number: 20110152314
    Abstract: The invention relates to a novel therapeutic application of tenatoprazole. Tenatoprazole and the salts thereof can be used in the production of a medicament for the treatment of atypical and esophageal symptoms of gastroesophageal reflux, gastrorrhagia and dyspepsia.
    Type: Application
    Filed: February 25, 2011
    Publication date: June 23, 2011
    Applicants: SIDEM PHARMA, MITSUBISHI PHARMA CORPORATION
    Inventors: Francois SCHUTZE, Suzy CHARBIT, Herve FICHEUX, Michel HOMERIN, Alain TACCOEN, Nathalie TACCOEN, Yoshio INABA
  • Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
    Publication number: 20100048518
    Abstract: The invention relates to a novel pharmaceutical combination. The inventive pharmaceutical composition comprises a combination of tenatoprazole and one or more anti-inflammatory agents selected from non-steroid anti-inflammatory agents and cyclooxygenase-2 inhibitors. The invention is suitable for the treatment of painful and inflammatory manifestations.
    Type: Application
    Filed: October 27, 2009
    Publication date: February 25, 2010
    Applicants: Sidem Pharma, Mitsubishi Pharma Corporation
    Inventors: Francois Schutze, Suzy Charbit, Hervé Ficheux, Michel Homerin, Alain Taccoen, Nathalie Taccoen, Yoshio Inaba
  • Enantiomer (-) of tenatoprazole and the therapeutic use thereof
    Patent number: 7652034
    Abstract: The invention relates to enantiomer (?) of tentoprazole. The inventive enantiomer (?) of tenatoprazole, or (?)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazol[4,5-b]pyridine exhibits improved pharmacokinetic properties which make it possible to use a once a day posology of a drug for relevant indications. The enantiomer (?) of tentoprazole can be used for treating digestive pathologies.
    Type: Grant
    Filed: February 1, 2006
    Date of Patent: January 26, 2010
    Assignee: Sidem Pharma
    Inventors: Suzy Charbit, Avraham Cohen, Herve Ficheux, Michel Homerin, Francois Schutze, Alain Taccoen
  • Monohydrated sodium salt of S-tenatoprazole and the use thereof in therapy
    Patent number: 7402593
    Abstract: The present invention relates to S-tenatoprazole monohydrated sodium salt, represented by the following formula and the use thereof in therapy for the treatment of digestive diseases.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: July 22, 2008
    Assignee: Sidem Pharma
    Inventors: Avraham Cohen, François Schutze, Suzy Charbit, Frédéric Martinet, Hervé Ficheux, Michel Homerin
  • Monohydrated sodium salt of s-tenatoprazole and the use thereof in therapy
    Publication number: 20070179176
    Abstract: The present invention relates to S-tenatoprazole monohydrated sodium salt, represented by the following formula and the use thereof in therapy for the treatment of digestive diseases.
    Type: Application
    Filed: June 17, 2005
    Publication date: August 2, 2007
    Inventors: Avraham Cohen, Francois Schutze, Suzy Charbit, Frederic Martinet, Herve Ficheux, Michel Homerin
  • Pharmaceutical composition combining tenatoprazole and an anti-inflamatory agent
    Publication number: 20060287284
    Abstract: The invention relates to a novel pharmaceutical combination. The inventive pharmaceutical composition comprises a combination of tenatoprazole and one or more anti-inflammatory agents preferably selected from non-steroid anti-inflammatory agents and cyclooxygenase-2 inhibitors. The invention is suitable for the treatment of painful and inflammatory manifestations.
    Type: Application
    Filed: October 21, 2003
    Publication date: December 21, 2006
    Applicants: Negma Gild, Mitsubishi Pharma Corporation
    Inventors: Francois Schutze, Suzy Charbit, Hervé Ficheux, Michel Homerin, Alain Taccoen, Nathalie Taccoen, Yoshio Inaba
  • Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist
    Publication number: 20060241136
    Abstract: The invention relates to a novel pharmaceutical combination. The inventive pharmaceutical composition, which is intended for the treatment of pathologies linked to gastric hyperacidity, comprises a combination of tenatoprazole and one or more histamine H2-receptor antagonists preferably selected from cimetidine, ranitidine, famotidine and nizatidine. The invention is particularly suitable for the treatment of duodenal and gastric ulcers and the symptoms of, and lesions caused by, gastroesophageal reflux.
    Type: Application
    Filed: October 21, 2003
    Publication date: October 26, 2006
    Inventors: Francois Schutze, Suzy Charbit, Hervé Ficheux, Michel Homerin, Alain Taccoen, Nathalie Taccoen, Yoshio Inaba
  • Enantiomer (-) of tenatoprazole and the therapeutic use thereof
    Publication number: 20060194832
    Abstract: The invention relates to enantiomer (?) of tentoprazole. The inventive enantiomer (?) of tenatoprazole, or (?)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazol[4,5-b]pyridine exhibits improved pharmacokinetic properties which make it possible to use a once a day posology of a drug for relevant indications. The enantiomer (?) of tentoprazole can be used for treating digestive pathologies.
    Type: Application
    Filed: February 1, 2006
    Publication date: August 31, 2006
    Inventors: Avraham Cohen, Suzy Charbit, Francois Schutze, Herve Ficheux, Michel Homerin, Alain Taccoen
  • Enantiomer (-) of tenatoprazole and the therapeutic use thereof
    Patent number: 7034038
    Abstract: The invention relates to enantiomer (?) of tentoprazole. The inventive enantiomer (?) of tenatoprazole, or (?)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazol[4,5-b]pyridine exhibits improved pharmacokinetic properties which make it possible to use a once a day posology of a drug for relevant indications. Said invention can be used for curing digestive pathologies.
    Type: Grant
    Filed: December 16, 2003
    Date of Patent: April 25, 2006
    Assignee: Sidem Pharma
    Inventors: Avraham Cohen, Suzy Charbit, François Schutze, Hervé Ficheux, Michel Homerin, Alain Taccoen
  • Enantiomer (-) of tenatoprazole and the therapeutic use thereof
    Publication number: 20050119298
    Abstract: The invention relates to enantiomer (?) of tentoprazole. The inventive enantiomer (?) of tenatoprazole, or (?)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfonyl]imidazol[4,5-b]pyridine exhibits improved pharmacokinetic properties which make it possible to use a once a day posology of a drug for relevant indications. Said invention can be used for curing digestive pathologies.
    Type: Application
    Filed: December 16, 2003
    Publication date: June 2, 2005
    Inventors: Avraham Cohen, Suzy Charbit, Francois Schutze, Herve Ficheux, Michel Homerin, Alain Taccoen